Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. (Q42989853)

12 November 2017

Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C. (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

1

1 reference

12 November 2017

8

1 reference

12 November 2017

0 references

3

López A

1 reference

12 November 2017

Francisco Borrás-Cuesta

7

object named as

Borrás-Cuesta F

1 reference

12 November 2017

García-Granero M

2

1 reference

12 November 2017

Casares N

4

1 reference

12 November 2017

García N

5

1 reference

12 November 2017

Civeira MP

6

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

12 November 2017

1 reference

12 November 2017

28

1 reference

12 November 2017

815-822

1 reference

12 November 2017

3

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

12 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Blood-borne non-A, non-B hepatitis: hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Hepatitis B and C viral infections in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Randomised trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Effects of interferon-alpha on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen-specific T cells.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Helper activity is required for the in vivo generation of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Impaired generation of anti-viral cytotoxicity against lymphocytic choriomeningitis and vaccinia virus in mice treated with CD4-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Insights on the amino acid side-chain interactions of a synthetic T-cell determinant

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Typing of hepatitis C virus isolates by DNA enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Sequence analysis of the core gene of 14 hepatitis C virus genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280332

7 January 2021

Identifiers

DOI

10.1002/HEP.510280332

1 reference

12 November 2017

1 reference